Search
for
Sort by
Research 91–120 of 1000+
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Facial Hair Restoration
- Eyelash Growth from Application of Bimatoprost in Gel Suspension to the Base of the Eyelashes
- Treatment of severe alopecia areata with baricitinib
- An evaluation of the safety and efficacy of bimatoprost for eyelash growth in pediatric subjects
- Tumor Necrosis Factor in Sepsis
- Phosphodiesterase inhibitors and prostaglandin analogues in dermatology: A comprehensive review
- Ethnic Considerations in Hair Restoration Surgery
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Ophthalmic manifestations of Demodex spp. infection – what should a dermatologist know?
- Management of Toxicities of Targeted Therapies
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study
- Analysis of Bimatoprost-Induced changes on Rabbits eyelash Follicle: Clinical and Electron microscopic study
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Farmácia Lusitana, Vila do Conde e nos Serviços Farmacêuticos do Hospital CUF, Porto
- Depression among Alopecia Areata Patients: Prevalence and associated factors in a Tunisian sample
- Ritlecitinib in severe alopecia areata: a profile of its use
- Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials
- Special Forms of Hair Transplantation
- Head and Neck Reconstruction
- 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study
- Correction to ‘Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study’
- Efficacy of Ritlecitinib in Patients with Alopecia Areata by Extent of Hair Loss: Results from the Phase 2b/3 and Phase 3 ALLEGRO Clinical Trials
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Evolution of long scalp hair in humans
- Congenital Trichomegaly of the Eyelashes
- Adaptive Triboelectric Nanogenerators for Long-Term Self-Treatment: A Review
- Baricitinib Treatment Increases Eyebrow and Eyelash Regrowth Up to 52 Weeks
- Vogt-Koyanagi-Harada Disease in which Poliosis and Alopecia Occurred after a Long Period of Time.